Cargando…
Continuous Brain-derived Neurotrophic Factor (BDNF) Infusion After Methylprednisolone Treatment in Severe Spinal Cord Injury
Although methylprednisolone (MP) is the standard of care in acute spinal cord injury (SCI), its functional outcome varies in clinical situation. Recent report demonstrated that MP depresses the expression of growth-promoting neurotrophic factors after acute SCI. The present study was designed to inv...
Autores principales: | Kim, Daniel H., Jahng, Tae-Ahn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822246/ https://www.ncbi.nlm.nih.gov/pubmed/14966352 http://dx.doi.org/10.3346/jkms.2004.19.1.113 |
Ejemplares similares
-
Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone
por: Bowers, Christian A., et al.
Publicado: (2016) -
Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
por: Bowers, Christian A., et al.
Publicado: (2016) -
Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury
por: Bi, Jiaqi, et al.
Publicado: (2022) -
Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury
por: Wurzelmann, Mary, et al.
Publicado: (2017) -
PS257. The effects of brain-derived neurotrophic factor (BDNF) micro-infusion on the impaired fear extinction of the animal model of PTSD.
por: Fuchikami, Manabu, et al.
Publicado: (2016)